Skip to main content
Clinical Trials/CTRI/2023/07/055724
CTRI/2023/07/055724
Not yet recruiting
Phase 2

Evaluation of post-operative analgesic effect of intraperitoneal instillation of Ropivacaine with Dexmedetomidine versus Ropivacaine with Nalbuphine in patients undergoing Laparoscopic Cholecystectomy - NI

Dr Shubham Gupta0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr Shubham Gupta
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Shubham Gupta

Eligibility Criteria

Inclusion Criteria

  • ASA (American Society of Anesthesiologists) grade I and II
  • Age group of 18\-60
  • Elective laparoscopic cholecystectomy

Exclusion Criteria

  • Patient who will not give consent.
  • ASA grade III and IV.
  • Allergy to study drug.
  • Second and third degree of heart block.
  • BMI (body mass index) \>30kg/m.Pregnancy and lactation.
  • Opioid addiction.
  • Conversion of laparoscopic to open cholecystectomy.
  • Patients on anti\-epileptic medication.
  • Drain inserted at surgical site.

Outcomes

Primary Outcomes

Not specified

Similar Trials